StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Raymond James Upgrades Teva Pharma (TEVA) to Outperform; Sees Growth Recovery in 2020
February 14, 2019 3:26 AM
(Updated - February 14, 2019 8:02 AM EST)(updated to add analyst comments)Raymond James analyst Elliot Wilbur upgraded Teva Pharma (NYSE ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot Upgrades
Upgrades
Next Articles
Teva Pharma (TEVA) PT Lowered to $20 at RBC Capital
February 14, 2019 6:50 AM